TERT and breast cancer: Moreover, given the published observation that the sensitivity for detection of the mutant TERT promoter in BC urine by Sanger sequencing is low [9, 10], we developed a Competitive Allele-Specific TaqMan PCR (castPCR) [22] (http://tools.lifetechnologies.com/content/sfs/brochures/cms_095916.pdf).